Investor Kit

Company Profile

Founded in 1995, Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.

Acorda has an industry leading pipeline of novel neurological therapies addressing a range of disorders, including Parkinson's disease, migraine and multiple sclerosis. Acorda markets two FDA-approved therapies, including INBRIJA™ (levodopa inhalation powder).

Stock Chart


Date Filing Description Download
05/06/21 8-K Current report filing
04/28/21 SC 13G/A Amended Statement of Ownership
04/23/21 DEF 14A Proxy Statement (definitive)
03/22/21 3 Initial Statement of Beneficial Ownership

Email Alerts

Un-subscribe from email alerts
Email Address *
Mailing Lists *